AIRLINK 73.00 Decreased By ▼ -2.16 (-2.87%)
BOP 5.35 Decreased By ▼ -0.10 (-1.83%)
CNERGY 4.31 Decreased By ▼ -0.08 (-1.82%)
DFML 28.55 Increased By ▲ 0.91 (3.29%)
DGKC 74.29 Increased By ▲ 2.29 (3.18%)
FCCL 20.35 Increased By ▲ 0.06 (0.3%)
FFBL 30.90 Decreased By ▼ -0.15 (-0.48%)
FFL 10.06 Increased By ▲ 0.09 (0.9%)
GGL 10.39 Increased By ▲ 0.12 (1.17%)
HBL 115.97 Increased By ▲ 0.97 (0.84%)
HUBC 132.20 Increased By ▲ 0.75 (0.57%)
HUMNL 6.68 Decreased By ▼ -0.19 (-2.77%)
KEL 4.03 Decreased By ▼ -0.17 (-4.05%)
KOSM 4.60 Decreased By ▼ -0.17 (-3.56%)
MLCF 38.54 Increased By ▲ 1.46 (3.94%)
OGDC 133.85 Decreased By ▼ -1.60 (-1.18%)
PAEL 23.83 Increased By ▲ 0.43 (1.84%)
PIAA 27.13 Decreased By ▼ -0.18 (-0.66%)
PIBTL 6.76 Increased By ▲ 0.16 (2.42%)
PPL 112.80 Decreased By ▼ -0.36 (-0.32%)
PRL 28.16 Decreased By ▼ -0.59 (-2.05%)
PTC 14.89 Decreased By ▼ -0.61 (-3.94%)
SEARL 56.42 Decreased By ▼ -0.91 (-1.59%)
SNGP 65.80 Decreased By ▼ -1.19 (-1.78%)
SSGC 11.01 Decreased By ▼ -0.16 (-1.43%)
TELE 9.02 Decreased By ▼ -0.12 (-1.31%)
TPLP 11.90 Decreased By ▼ -0.15 (-1.24%)
TRG 69.10 Decreased By ▼ -1.29 (-1.83%)
UNITY 23.71 Increased By ▲ 0.06 (0.25%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
BR100 7,434 Decreased By -20.9 (-0.28%)
BR30 24,206 Decreased By -44.4 (-0.18%)
KSE100 71,359 Decreased By -74.1 (-0.1%)
KSE30 23,567 Increased By 0.5 (0%)
Brecorder Logo
Apr 24, 2024 اردو ► PRINT EDITION ► BR MARKETS ► Dollar to PKR ►

research

COVID-19 caused $220 billion of global dividend cuts in 2020: Research
World

COVID-19 caused $220 billion of global dividend cuts in 2020: Research

  • According to research, the coronavirus pandemic led to a sharp decline in global dividends last year, with the amount of investor payouts declining by 12.6% to $1.26 trillion.
  • As the public health crisis impacted every corner of the globe, prompting lockdowns and inhibiting economic activity, dividend cuts amounted to $220 billion, according to the Global Dividend Index.
Updated 22 Feb, 2021 03:42pm
Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen
World

Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen

  • The British researchers behind the trial say data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world
  • The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca vaccine
Published 04 Feb, 2021 03:14pm
Twitter grants academics full access to public data, but not for suspended accounts
World

Twitter grants academics full access to public data, but not for suspended accounts

  • Twitter Inc on Tuesday opened free access to its new application programming interface (API) software for academic researchers, enabling them to study public conversations on its platform.
  • Twitter said, with the new product, academic researchers will be able to tap into all the tools released to date on the new API platform, which will enable them to listen to and analyze public conversations.
Published 27 Jan, 2021 10:09am
£100m donated to Oxford University for antibiotic resistance research
World

£100m donated to Oxford University for antibiotic resistance research

  • On Tuesday, Oxford University received a donation of £100 million ($136 million) to research growing resistance to antibiotics.
  • The donation, contributed by British multinational chemicals production company Ineos, is one of the largest donations given to Oxford University in its long history.
Published 19 Jan, 2021 07:11pm
Indus Hospital denies Global Fund allegations of misappropriation of funds
Pakistan

Indus Hospital denies Global Fund allegations of misappropriation of funds

  • Dr. Abdul Bari Khan, the Chief Executive Officer at the Indus Hospital, rejected all such reports, terming them "misleading, exaggerated and not based on facts".
  • Yesterday, The Global Fund, international financing and partnership organization, claimed that Indus hospital had committed a $4.2 million procurement fraud from a grant that was meant to eradicate tuberculosis (TB).
Updated 16 Jan, 2021 03:41pm